Kathy Q. Cai

6.2k citations
117 papers · 3.7k indexed · 1 hit paper · h-index 34

Kathy Q. Cai

114 papers receiving 3.7k citations

Hit Papers

Ferroptotic cell death triggered by conjugated linolenic ...2021202620222024202150100150

Peers

Kathy Q. Cai
Comparison fields: 5 of 118
  • Molecular Biology 2.2k
  • Oncology 1.0k
  • Cancer Research 940
  • Pulmonary and Respiratory Medicine 936
  • Cell Biology 387
Replace Viví Ann Flørenes with:
Viví Ann Flørenes Norway
Kazuhiro Sentani Japan
Burkhard Helmke Germany
Rosemary Foster United States
Zhenfeng Duan United States
Chouhei Sakakura Japan
Frank Hilberg Austria
Takeshi Nagasaka Japan
Jianfei Huang China
Yoshiyuki Tsukamoto Japan
Kathy Q. Cai relative to Viví Ann Flørenes Norway Viví Ann Flørenes's profile →
Citations per field
00.5×10×
Viví Ann Flørenes · 1×
Citations per year

Countries citing papers authored by Kathy Q. Cai

Since Specialization
Citations

This map shows the geographic impact of Kathy Q. Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Q. Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Q. Cai more than expected).

Fields of papers citing papers by Kathy Q. Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Q. Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Q. Cai. The network helps show where Kathy Q. Cai may publish in the future.

Co-authorship network of co-authors of Kathy Q. Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Q. Cai. A scholar is included among the top collaborators of Kathy Q. Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Q. Cai. Kathy Q. Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 2
3 12
4 15
5 1
6 19
7 12
8 41
9 26
10 23
11 59
12 79
13 28
14 25
15 35
16 107
17 37
18 21
19 101
20 111

About Kathy Q. Cai

Kathy Q. Cai is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 117 papers that have together received 3.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Cancer Research (940 citations), Oncology (1.0k citations) and Reproductive Medicine (313 citations). Kathy Q. Cai has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Andrew K. Godwin, Xiang‐Xi Xu, Callinice D. Capo‐chichi, Andres J. Klein–Szanto, Joseph R. Testa, Jinsong Liu, Dong‐Hua Yang, Elizabeth R. Smith, Gong Yang and Jennifer L. Smedberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026